1- Jellinger KA. What is new in degenerative disorders? Wien Klin Wochenschr 1999; 111: 682-704.
2- Cummings BH, Vinters HV, Cole MG, Khachaturian ZS. Alzheimer’s disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998; 51: 2-17.
3- Anuario demográfico de Cuba 2000. Centro de Estudios de la Población y Desarrollo. Oficina Nacional de Estadísticas.
4- Evans DA, Funkenstin HH, Albert MS. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. Journal of the American Medical Association 1989; 262: 2551-2556.
5- Tolnay M, Probst A. Neuropathology and Genetics of Dementia. (Advances in experimental medicine and biology; v. 487. Kluver Academic / Plenum Publishers, New York, 2001.
6- Dickson DW. Neuropathology of Alzheimer’s disease and other dementias. Clinics in Geriatric Medicine 2001; 17: 209-227.
7- Honing LS, Mayeux R. Natural history of Alzheimer’s disease. Aging Clin. Exp. Re 2001;13:171-182.
8- Barker WW, Luis ChA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shephered E, Sevush S, Graff-Radford N, Newland D, Todd M, Millar B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Peral G, Dickson D, Duara R. Relative Frecuencies of Azheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, Hippocampal Sclerosis in the State of Florida Brain Bank. Alzheimer Disease and Associated Disorders 2002;16(4):203-212.
9- Markesbery WR: Overview of dementing disorders. En Markesbery WR (ed): Neuropathology of Dementing Disorders. London, Arnold, 1998, pp 1-24.
10- Molina O, Cardozo D, Cardozo J. Reevaluación de las causas de demencia en Maracaibo, Venezuela. Rev Neurol 2000; 30 (2): 115-117.
11- Llibre Rodriguez JJ. La enfermedad de Alzheimer en los umbrales del siglo 21. Avances Médicos de Cuba 2000;23:34-36.
12- Mirra SS, Hart MN, Terry RD. Making the Diagnosis of Alzheimer’s Disease. A Primer for Practicing Pathologist. Arch Pathol Lab Med 1993;117:132-144.
13- Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
14- Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994 Feb;24(1):145-53.
15- Flowers D, Harasty J, Halliday G, Kril J. Microwave Modification of the Methenamine Silver Technique for the Demonstration of Alzheimer - Type Pathology. The J Histotechnol 19:33;1996.
16- Morris JC. The Nosology of Dementia. Neurologic Clinics 2000; 18: 773-788.
17- The National Institute on Aging and Reagan Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Consensus Recomendentions for the Postmortem Diagnosis of Alzheimer’s Disease. Neurobiol of Aging 1997; 18 (Suppl 1): S1-S3.
18- McKeith, Galasco D, Kosaka K, Perry EK, Dickson DW, Hansen LA. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Woorkshop. Neurology 1996;47:1113-1124.
19- Hinton L, Franz C, Friend J. Pathways to Dementia Diagnosis. Evidence for Cross-Ethnic Differences. Alzheimer Dis Assoc Disord 2004;18:134-144.
20- Crystal HA, Dickson D, Davis P, Masur D, Grober E, Lipton RB. The relative Frecuency of "Dementia of Unknown Etiology" Increases with Age and Is Nearly 50 % in Nonagenarians. Arch Neurol 2000; 57:713-719.
21- Enciclopédia Encarta. Biblioteca de Consulta. Microsoft. 2002.
22- Kukul WA, Larson EB. Distinguishing Alzheimer’s disease from other dementias: questionnaire responses of close relative and autopsy results. J Am Geriatr Soc 1989;37:521-527.
23- David PB, White H, Price JL, McKeel D, Robins LN. Retrospective Postmortem Dementia Assessment, Validation of a New Clinical Interviw to Assist Neuropathologic Study. Arch Neurol 1991;48:613-617.
24- Jorm A. The informant Quetionnaire on Cognitive Decline in the Elderly (IQCODE): a review. International Psychogeriatrics 2004;16(3):1-19.
25- Hamilton RL. Lewy Bodies in Alzheimer’s Disease: A Neuropathological Review of 145 Cases Using alpha synuclein immunohistochemistry. Brain Pathology 2000;10:378-384.
26- Fontán A, Zarranz JJ, Camarero C, Forcadas I. Demencia por metástasis cerebral miliar de un hepatocarcinoma. Med Clin (Barc) 1989;93:421-423.